Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted tetralins, chromans and related compounds in the treatment and related compounds in the treatment of asthma, arthritis and related diseases

Substituted tetralins, chromans and related compounds in the treatment and related compounds in the treatment of asthma, arthritis and related diseases

US Patent 5998451 · Granted Dec 7, 1999

Estimated economic value: $328,785,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rapamycin for the treatment of lymphangioleiomyomatosis2024
Oxabicycloheptane prodrugs2024
Rapamycin for the treatment of lymphangioleiomyomatosis2023
Inhalable rapamycin formulation for treating age-related conditions2023
Inhalable rapamycin formulation for the treatment of pulmonary hypertension2022
Oxabicycloheptane prodrugs2022
Rapamycin for the treatment of lymphangioleiomyomatosis2021
Inhalable rapamycin formulation for treating age-related conditions2021
Apoptosis signal-regulating kinase inhibitors2021
Amine prodrugs of pharmaceutical compounds2021
Oxabicycloheptane prodrugs2020
Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP22019